1 – 3 of 3
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2023
- 
                        Mark
        HLA Class I Genotype Is Associated with Relapse Risk after Allogeneic Stem Cell Transplantation for NPM1-Mutated Acute Myeloid Leukemia
    
    - Contribution to journal › Article
 
- 2021
- 
                        Mark
        Comparison of RNA- and DNA-based methods for measurable residual disease analysis in NPM1-mutated acute myeloid leukemia
    (2021) In International Journal of Laboratory Hematology- Contribution to journal › Article
 
- 2019
- 
                        Mark
        Measurable residual disease testing for personalized treatment of acute myeloid leukemia
    
    - Contribution to journal › Scientific review
 
